financetom
Business
financetom
/
Business
/
Sportradar's Q3 Earnings, Revenue Advance; 2024 Revenue Guidance Lifted -- Shares Rise Pre-Bell
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Sportradar's Q3 Earnings, Revenue Advance; 2024 Revenue Guidance Lifted -- Shares Rise Pre-Bell
Nov 9, 2024 12:08 PM

08:16 AM EST, 11/07/2024 (MT Newswires) -- Sportradar Group ( SRAD ) reported Q3 earnings Thursday of 0.11 euros ($0.12) per diluted Class A share, up from 0.01 euros a year earlier.

Analysts polled by Capital IQ expected 0.03 euros.

Total revenue for the quarter ended Sept. 30 was 255.2 million euros, up from 201 million euros a year earlier.

Analysts surveyed by Capital IQ expected 238 million euros.

The sports technology company said it now expects 2024 revenue of at least 1.09 billion euros, up from its prior guidance of 1.07 billion euros. Analysts polled by Capital IQ expect 1.07 billion euros.

Shares of the company were up more than 7% in recent Thursday premarket activity.

Price: 13.60, Change: +0.95, Percent Change: +7.50

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Update: Avid Bioservices Prices $160 Million Convertible Notes Offering; Shares Slump
Update: Avid Bioservices Prices $160 Million Convertible Notes Offering; Shares Slump
Mar 7, 2024
01:58 PM EST, 03/07/2024 (MT Newswires) -- (Updates with stock price movement in the headline and first paragraph) Avid Bioservices ( CDMO ) shares were down about 30% in recent Thursday trading, a day after the firm priced its $160 million of 7% convertible senior notes due 2029 in a private placement. The conversion rate for the notes will initially...
Astra-Sanofi's RSV therapy 'highly effective' against infant hospitalizations, CDC study shows
Astra-Sanofi's RSV therapy 'highly effective' against infant hospitalizations, CDC study shows
Mar 7, 2024
March 7 (Reuters) - AstraZeneca ( AZN ) and Sanofi's antibody therapy was 90% effective in protecting infants from hospitalizations associated with respiratory syncytial virus (RSV), a study by the U.S. Centers of Disease Control and Prevention showed on Thursday. ...
Suncor signs agreement on potential Canadian oil lease with First Nation
Suncor signs agreement on potential Canadian oil lease with First Nation
Mar 7, 2024
WINNIPEG, Manitoba, March 7 (Reuters) - Canada's second-biggest oil producer, Suncor Energy ( SU ), has signed a memorandum of understanding with Fort McKay First Nation to assess a potential oil sands lease on the Indigenous community's land, the First Nation and company said on Thursday. WHY IT'S IMPORTANT Some First Nations like Fort McKay, located 50 km (31 miles)...
EU's Breton warns gatekeepers against silencing developers in Apple, Epic Games spat
EU's Breton warns gatekeepers against silencing developers in Apple, Epic Games spat
Mar 7, 2024
BRUSSELS, March 7 (Reuters) - EU industry chief Thierry Breton on Thursday warned large online platforms against threatening developers, saying he would look into Apple's ( AAPL ) move to prevent Fortnite video-game maker Epic Games from launching its own online marketplace on iPhones and iPads in Europe as a matter of priority. The iPhone maker on Wednesday terminated a...
Copyright 2023-2025 - www.financetom.com All Rights Reserved